Literature DB >> 11258636

Catecholamines response of high performance wheelchair athletes at rest and during exercise with autonomic dysreflexia.

A Schmid1, A Schmidt-Trucksäss, M Huonker, D König, I Eisenbarth, H Sauerwein, C Brunner, M J Storch, M Lehmann, J Keul.   

Abstract

Autonomic dysreflexia presents a special situation in high-lesion spinal cord injury, however, intentionally or self-induced autonomic dysreflexia directly before or during competition to increase performance, so called 'boosting', is also being reported. In order to examine the influence of autonomic dysreflexia on plasma catecholamines, cardiocirculatory and metabolic parameters, 6 spinal cord injured wheelchair athletes with high-level lesions underwent wheelchair ergometry without (ST1) and with (ST2) autonomic dysreflexia. At the point of exhaustion significantly higher values for norepinephrine and epinephrine were observed in ST2 than in ST1. During autonomic dysreflexia a significantly higher peak performance (77.5 vs. 72.5 watt), higher peak heart rate (161 vs. 149 x min(-1)), and peak oxygen consumption (1.96 vs. 1.85 l x min(-1)), with comparable peak lactate (7.11 vs. 7.00 mmol x l(-1)) were reached on average. The blood pressure values in ST2 were partially hypertensive and higher than in ST1. In conclusion, autonomic dysreflexia, as a sympathetic spinal reflex, leads to a higher release of catecholamines during exercise. This results in higher peak performance, peak heart rate, peak oxygen consumption, and higher blood pressure values. The peak lactate, as an indicator of the anaerobic lactate metabolism, was unchanged. However, autonomic dysreflexia presents an unpredictable risk, caused predominantly by hypertensive blood pressure values, for high-lesion spinal cord injured persons at rest and more so during exercise; it is seen as a prohibited manipulation by the doping guidelines of the International Paralympic Committee.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11258636     DOI: 10.1055/s-2001-11330

Source DB:  PubMed          Journal:  Int J Sports Med        ISSN: 0172-4622            Impact factor:   3.118


  10 in total

Review 1.  [Doping in disabled sports. Doping control activities at the Paralympic Games 1984-2008 and in Germany 1992-2008].

Authors:  Mario Thevis; Peter Hemmersbach; Hans Geyer; Wilhelm Schänzer
Journal:  Med Klin (Munich)       Date:  2009-12-30

Review 2.  Boosting in Elite Athletes with Spinal Cord Injury: A Critical Review of Physiology and Testing Procedures.

Authors:  Cameron M Gee; Christopher R West; Andrei V Krassioukov
Journal:  Sports Med       Date:  2015-08       Impact factor: 11.136

3.  Evaluation and Management of Autonomic Dysreflexia and Other Autonomic Dysfunctions: Preventing the Highs and Lows: Management of Blood Pressure, Sweating, and Temperature Dysfunction.

Authors:  Andrei Krassioukov; Todd A Linsenmeyer; Lisa A Beck; Stacy Elliott; Peter Gorman; Steven Kirshblum; Lawrence Vogel; Jill Wecht; Sarah Clay
Journal:  Top Spinal Cord Inj Rehabil       Date:  2021

4.  The preparticipation evaluation for athletes with disability.

Authors:  Jonathan P Hawkeswood; R O'Connor; H Anton; H Finlayson
Journal:  Int J Sports Phys Ther       Date:  2014-02

5.  The ability of heart rate or perceived exertion to predict oxygen uptake varies across exercise modes in persons with tetraplegia.

Authors:  Jessie R Shea; Barbara L Shay; Kristine C Cowley
Journal:  Spinal Cord       Date:  2021-08-30       Impact factor: 2.772

Review 6.  "Boosting" in Paralympic athletes with spinal cord injury: doping without drugs.

Authors:  Filomena Mazzeo; Stefania Santamaria; Alessandro Iavarone
Journal:  Funct Neurol       Date:  2015 Apr-Jun

Review 7.  Hypertension in athletes.

Authors:  John J Leddy; Joseph Izzo
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-04       Impact factor: 3.738

8.  [Formula: see text]  [Formula: see text]  [Formula: see text] [Formula: see text]Evaluation and Management of Autonomic Dysreflexia and Other Autonomic Dysfunctions: Preventing the Highs and Lows.

Authors:  Andrei Krassioukov; Todd A Linsenmeyer; Lisa A Beck; Stacy Elliott; Peter Gorman; Steven Kirshblum; Lawrence Vogel; Jill Wecht; Sarah Clay
Journal:  J Spinal Cord Med       Date:  2021-07       Impact factor: 2.040

9.  Salivary alpha amylase not chromogranin A reflects sympathetic activity: exercise responses in elite male wheelchair athletes with or without cervical spinal cord injury.

Authors:  Christof A Leicht; Thomas A W Paulson; Victoria L Goosey-Tolfrey; Nicolette C Bishop
Journal:  Sports Med Open       Date:  2017-01-04

10.  A cautionary note for researchers treating mice with the neurotransmitter norepinephrine.

Authors:  Vance B Matthews; Caroline Rudnicka; Markus P Schlaich
Journal:  Biochem Biophys Rep       Date:  2018-08-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.